Ebola Disease Knowledge and Vaccine Acceptance in the Democratic Republic of the Congo
Merritt, S.; Kindrachuk, J.; Nkamba, D.; Hoff, N. A.; Kalengi, H.; Halbrook, M.; Kamba, L.; Beya, M.; Petrichko, S.; Wallace, H. L.; Luhata, C.; Kaba, D.; Rimoin, A. W.
Show abstract
We report general acceptance (79.0%) of Ebola vaccination in the Democratic Republic of the Congo (DRC) between 2023-2024 (n=5,062). Acceptance varied significantly by province with acceptance ranging from 47.6% in Kongo Central to 92.1% in Tshuapa province and was highest among healthcare workers. While Ebola vaccine acceptance and disease knowledge are relatively strong nationally in the DRC, regional differences do exist and may impact future vaccine rollout.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Effectiveness of Typhoid Conjugate Vaccine in Zimbabwe used in response to an outbreak among children and young adults: a matched case control study 95%
- COVID-19 vaccine acceptance and its socio-demographic and emotional determinants: a multi-country cross-sectional study 94%
- COVID-19 impact on routine immunisations for vaccine-preventable diseases: Projecting the effect of different routes to recovery 93%
Similar papers in this journal
- Public perceptions of Ebola vaccines and confidence in health services to treat Ebola, malaria, and tuberculosis: Findings from a cross-sectional household survey in Uganda, 2020 95%
- COVID-19 vaccine hesitancy and conspiracy beliefs in Togo: Findings from two cross-sectional surveys 94%
- Active vaccine safety surveillance: Experience from a prospective cohort event monitoring study of COVID-19 vaccines in Kenya 94%
Similar papers in this journal
- Cost analysis of a nationwide typhoid conjugate vaccine campaign in Burkina Faso 95%
- COVID-19 vaccine hesitancy and refusal and associated factors in an adult population in Saskatchewan, Canada: Evidence from predictive modelling 93%
- Have you heard of Rift Valley fever? Findings from a multi-country study in East and Central Africa 93%
Similar papers in this journal
- Vaccine Preventable Disease Seroprevalence In a Nationwide Assessment of Timor-Leste (VASINA-TL) - study protocol for a population-representative cross-sectional serosurvey 94%
- The acceptance of covid-19 vaccines in Sub-Saharan Africa: Evidence from 6 national phone surveys 94%
- Factors associated with vaccine coverage improvements in Senegal 93%
Similar papers in this journal
- Assessing the feasibility of Phase 3 vaccine trials against Marburg Virus Disease: a modelling study 92%
- The projected cost-effectiveness and budget impact of Alternative HPV Vaccines in Senegal: A Modelling Study 92%
- Psychosocial factors affecting COVID-19 vaccine uptake in the UK: a prospective cohort study (CoVAccS – wave 3) 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.